We previously identified 11 yeast proteins whose over-expression facilitated the *de novo* appearance of the \[*PSI^+^*\] prion in an unbiased screen: Cyc8, Lsm4, New1, Nup116, Pin2, Pin3, Pin4, Ste18, Swi1, Ure2, Yck1[@R8]. As the appearance of \[*PSI^+^*\] was also facilitated by the presence of the established prions \[*PIN^+^*\] or \[URE3\], and the protein determinant of \[URE3\] was among the 11 proteins identified, we hypothesized that some of the other 10 proteins could also form prions[@R8]. This was further supported by the observation that all 11 proteins contained domains with an unusually high glutamine and asparagine (QN) content. Such QN-rich domains are found in all known yeast prions as part of the "prion-domain" required for prion formation and propagation[@R3],[@R4]. Here we show that one of these proteins, Cyc8 can indeed form a prion.

Mutations in *CYC8* cause slow growth, defects in sporulation and mating, high iso-2-cytochrome *c*, flocculation and invertase de-repression[@R6],[@R9],[@R10]. Since inactivation of Cyc8 either by mutation or prion formation should manifest as a loss-of-function phenotype[@R2], we used the *cyc8* mutant phenotype of increased levels of iso-2-cytochrome *c*[@R9] to initially select for the prion. Yeast needs cytochrome *c* to grow on the non-fermentable carbon source lactate[@R9]. As 95% of a cell's cytochrome *c* (iso-1) is encoded by *CYC1*, *cyc1* mutants cannot grow if lactate is the only carbon source. However, a *cyc1* mutant can grow on lactate if the level of iso-2-cytochrome *c*, encoded by *CYC7,* is increased by inactivating the Cyc8-Tup1 repressor complex that represses synthesis of iso-2-cytochrome[@R7],[@R9] **(**[Figure 1a](#F1){ref-type="fig"}). Thus, to screen for cells propagating a Cyc8 prion, we selected for *cyc1Δ* yeast cells that grew well on lactate.

The *de novo* appearance of a prion is generally a rare event, but the transient overproduction of the protein's prion domain greatly enhances its chance of misfolding into a prion[@R2],[@R3]. Thus, we over-expressed the C-domain of Cyc8 (aa: 465--966) which is not essential for Cyc8 function and contains a highly Q-rich segment (52% of aa: 491--668 are Q)[@R11],[@R12]. This domain organization is reminiscent of the known yeast prion proteins, where the functional and QN-rich prion domains are separate and distinct[@R3]. While lactate^+^ (Lac^+^) colonies appeared spontaneously in a *cyc1*Δ haploid strain presumably due to recessive spontaneous Lac^+^ mutations e.g. *cyc8* mutations[@R9], we found that overproduction of Cyc8(465--966) enhanced the appearance of Lac^+^ derivatives by more than 100-fold (data not shown). When the screen was repeated in a *cyc1*Δ/*cyc1*Δ diploid, Lac^+^ derivatives appeared at a frequency of 1.7 ± 0.4 × 10^−5^ (n=3), while virtually no Lac^+^ derivatives were seen in control plates without Cyc8 over-expression ([Figure 1b](#F1){ref-type="fig"}) because recessive spontaneous Lac^+^ mutations were hidden in the diploid. We call the proposed, Lac^+^, prion form of Cyc8, \[*OCT*^+^\]. Since inactivation of Cyc8, either by mutation or prion formation, would inhibit sporulation of *MAT***a**/*MAT*α diploid cells[@R6] and compromise the ability of *MAT*α**/***MAT*α cells to mate[@R6], we isolated \[*OCT*^+^\] candidates from a *cyc1Δ/cyc1Δ MAT***a**/*MAT***a** diploid, which can mate and thus allow genetic manipulations to examine prion propagation. We examined three independent \[*OCT^+^*\] isolates from *MAT***a**/*MAT***a** cells and even after loss of the Cyc8(465--966) encoding plasmid, these \[*OCT*^+^\] candidates remained Lac^+^ ([Figure 1c](#F1){ref-type="fig"}) and exhibited additional phenotypes previously associated with Cyc8's loss-of-function[@R6],[@R10]: higher levels of invertase activity even under glucose-repressed conditions (constitutive expression) and increased flocculence compared to Lac^−^ cells **(**[Figure 1d](#F1){ref-type="fig"}), thereby indicating de-repression of *SUC2* and *FLO1* genes respectively. All subsequent analyses were done with one of these \[*OCT^+^*\] derivatives following loss of the Cyc8(465--966) encoding plasmid.

While the Mendelian mutations in *cyc8*, documented so far, are recessive[@R9],[@R10], an \[*OCT^+^*\] prion should be dominant over an \[*oct*^−^\] state since the \[*OCT^+^*\] Cyc8 in the zygote should convert the \[*oct*^−^\] Cyc8 into the prion form. Indeed, when *MAT***a**/*MAT***a** \[*OCT^+^*\] candidates were crossed to an \[*oct*^−^\] *cyc1Δ* haploid the resulting triploids were \[*OCT^+^*\]: they grew on lactate and showed constitutive invertase activity **(**[Figure 2a](#F2){ref-type="fig"}).

Furthermore, when \[*OCT^+^*\] candidates were transformed with a plasmid expressing functional Cyc8 (kind gift of R. Trumbly), all transformants remained \[*OCT^+^*\]: they had Lac^+^, high invertase phenotypes ([Figure 2b](#F2){ref-type="fig"}). This observed lack of restoration of Cyc8 function in \[*OCT^+^*\] cells is consistent with the expected inactivation of the plasmid encoded Cyc8 by sequestration into prion aggregates. In controls, the same plasmid restored function to a *cyc8* deletion ([Figure 2b](#F2){ref-type="fig"}). In contrast, when \[*OCT^+^*\] cells were transformed with a plasmid expressing the N-terminal functional fragment (aa: 1--453) of Cyc8[@R12] lacking the QN-rich carboxyl terminal region, Cyc8 function was successfully restored, as revealed by the invertase assay ([Figure 2b](#F2){ref-type="fig"}). These data are consistent with the QN-rich region of Cyc8 being its prion determining domain which predicts that a Cyc8 functional fragment lacking the QN-rich region would fail to join the prion aggregates in \[*OCT^+^*\] and consequently restore Cyc8 function.

As the Hsp104 chaperone that dissolves non-specific protein aggregates, is indispensable for the heritability of all known yeast prions[@R3],[@R4],[@R13], we tested if it is required for the maintenance of \[*OCT^+^*\]. We transiently inhibited Hsp104 by growing \[*OCT^+^*\] cells on medium containing 4 mM guanidine hydrochloride (GuHCl)[@R3],[@R14]. Indeed, the \[*OCT^+^*\] cells lost their ability to utilize lactate and ferment sucrose after growth on GuHCl but not when grown for similar generations without GuHCl ([Figure 3a](#F3){ref-type="fig"}). These \[*oct*^−^\] cells, obtained after GuHCl treatment of \[*OCT^+^*\], remained \[*oct*^−^\], even when subcloned for several passages on GuHCl-less glucose-rich medium, as they did not spontaneously give rise to Lac^+^ colonies when spread on synthetic lactate plates ([Supplementary Figure S1 left](#SD1){ref-type="supplementary-material"}). Furthermore, as expected of a prion phenotype[@R2], but unlike viruses or other nucleic acid elements, \[*OCT^+^*\] could be induced to re-appear in the cured \[*oct*^−^\] cells ([Supplementary Figure S1](#SD1){ref-type="supplementary-material"}).

We also blocked Hsp104's activity in \[*OCT^+^*\] cells for a few generations by expressing a dominant negative *HSP104-KT* allele[@R13]. \[*OCT^+^*\] cells lost their ability to utilize lactate and ferment sucrose following transient expression of *HSP104-KT*, while controls in which *HSP104-KT* was never expressed remained \[*OCT^+^*\] ([Figure 3b](#F3){ref-type="fig"}). Thus, sustained Hsp104 activity is essential for propagation of \[*OCT^+^*\], strongly suggesting that its inheritance is protein-based.

While over-expression of Hsp104 cures cells of \[*PSI^+^*\][@R13], it did not cure cells of \[*OCT^+^*\]: 14 transformants of an \[*OCT^+^*\] strain with plasmid pES5 (a kind gift of S. Lindquist) encoding Hsp104 from a *GAL* promoter remained \[*OCT^+^*\] even after Hsp104 was over-produced by growth on 2% galactose medium (data not shown). Possibly, the \[*OCT^+^*\] prion aggregates are similar to the \[URE3\], \[*PIN^+^*\] and \[*SWI^+^*\] aggregates that are also not cured by elevated Hsp104 levels[@R3],[@R4].

Since prions are infectious proteins, the transfer of cytoplasm without genetic material (cytoduction) from a prionbearing donor cell can infect a recipient that expresses the corresponding protein. To ask if \[*OCT^+^*\] could be transmitted by cytoduction, \[*OCT^+^*\] and control isogenic \[*oct*^−^\] cells were crossed to an \[*oct*^−^\] recipient that contained the *kar1-Δ15* mutation that inhibits karyogamy[@R15] but permits cell fusion and cytoplasmic mixing. Cells that budded off from these heterokaryons and contained only the recipient haploid nucleus (i.e. cytoductants) were selected and tested for the ability to grow on lactate: 24 of 57 vs. 0 of 63 cytoductants tested from the \[*OCT^+^*\] and \[*oct*^−^\] crosses respectively grew on lactate. The Lac^+^ phenotype in these cytoductants was associated with constitutive invertase activity, was dominant and was cured by growth on 4 mM GuHCl (data not shown), indicating that \[*OCT^+^*\] had been transmitted via cytoduction. Since the *CYC8* allele in the recipient was tagged with GFP we had hoped to score for \[*OCT^+^*\] cytoductants directly by observing fluorescent foci (dots) in \[*OCT^+^*\] but not \[*oct*^−^\] cells, but the low intensity of the GFP fluorescence thwarted such differentiation.

However, when a Cyc8-YFP fusion protein[@R16] was over-expressed at a modest level from a copper inducible plasmid pCUP-CYC8YFP (a kind gift of S. Lindquist), in addition to the diffuse nuclear fluorescence in both \[*OCT^+^*\] and \[*oct*^−^\] cells, punctate fluorescent dots appeared in the cytoplasms of \[*OCT^+^*\] but not \[*oct*^−^\] cells ([Figure 4a](#F4){ref-type="fig"}). This is suggestive of a prion-like decoration of pre-formed Cyc8 aggregates by Cyc8-YFP in the cytoplasms of the \[*OCT^+^*\] cells and is analogous to results seen with other yeast prions[@R3],[@R4],[@R17]. However, since even in \[*oct*^−^\] cells, Cyc8 is part of large detergent resistant protein complexes, we were unable to identify detergent resistant \[*OCT^+^*\]-specific prion aggregates (data not shown).

Next, we tested if \[*OCT^+^*\] cell-lysates could infect an \[*oct*^−^\] cell. Pre-cleared cell-lysate obtained from an \[*OCT^+^*\] strain was introduced into \[*oct*^−^\] cells by co-transformation with a centromeric *LEU2* plasmid (pRS315) as described previously for other prions[@R19],[@R20]. Leu^+^ transformants were assayed for growth on lactate. When the cell extracts were respectively made from \[*OCT^+^*\] and \[*oct*^−^\] cells, 7 out of 170 vs 0 out of 160 Leu^+^ transformants became Lac^+^. These Lac^+^ transformants also exhibited high invertase activity and both phenotypes were cured on GuHCl (data not shown). The observed transformation efficiency of 4% for \[*OCT^+^*\], which is within the range of 3--11% infection previously observed for variants of \[*PIN^+^*\][@R18], indicates infection.

If \[*OCT^+^*\] is indeed a prion form of the Cyc8 protein, then transient loss of the Cyc8 protein should cure cells of \[*OCT^+^*\]. As predicted, when we replaced *CYC8* with *URA3* in an \[*OCT^+^*\] strain, 9 of 9 independent deletions, but 0 of 40 controls, lost \[*OCT^+^*\]. Deletions were scored for \[*OCT^+^*\] after restoring Cyc8 protein by crossing them to an \[*oct*^−^\] *CYC8cyc1Δ* strain ([Figure 4b](#F4){ref-type="fig"}).

As the Cyc8 protein represses transcription of numerous yeast genes[@R6],[@R7], its inactivation by prion formation is expected to de-repress these genes. Indeed, *lacZ* fusions showed that expression of two Cyc8 regulated genes, *CYC7* and *ANB1* is de-repressed in \[*OCT^+^*\] cells ([Figure 5a](#F5){ref-type="fig"}). Furthermore, as measured with real-time PCR, the mRNA levels of five Cyc8-repressed genes[@R7], *CYC7*, *RNR3*, *FLO1*, *ANB1*, and *SUC2*, were elevated in \[*OCT^+^*\] cells but less than a *cyc8Δ* control suggesting a partial loss-of Cyc8's function in \[*OCT^+^*\] cells ([Figure 5b](#F5){ref-type="fig"}).

Our data establishes that the global transcriptional repressor Cyc8 can form and propagate a prion. This together with the recent evidence that another global transcriptional regulator, Swi1 also enters a prion state[@R4], raises the possibility that prionization of these proteins may have a functional role. Interplay of the Cyc8-Tup1 repressor and the Swi-Snf activator-repressor complexes determines the expression fate of many genes by remodeling chromatin in promoter and upstream regions[@R21],[@R22]. Thus prionization of Cyc8 and Swi1 may provide an additional level of control over the dynamics of chromatin remodeling. Furthermore, since heterologous prions appear to cross-talk *in vivo* either facilitating prionization[@R8] or causing prion-loss[@R23], interactions between \[*OCT^+^*\] and \[*SWI^+^*\], could generate a novel regulatory mechanism for repression and de-repression of target genes.

Methods {#S1}
=======

Yeast culture and Media {#S2}
-----------------------

Standard yeast media were used[@R24]. Yeast cells were grown at 30 °C. YPD is complex glucose rich medium[@R24]. Synthetic glucose-Ura, -Leu etc. are synthetic complete glucose medium respectively lacking uracil and leucine etc. Lactate-Ura is synthetic lactate medium[@R9] lacking uracil. Expression of plasmid pGAL-HSP104KT was induced on synthetic complete medium containing 2% galactose and 1% raffinose but lacking glucose and uracil. Since \[*OCT^+^*\] can be lost spontaneously, and under repeated selection homozygous genetic mutations that confer the Lac^+^ phenotype will appear, we propagated \[*OCT^+^*\] cells on glucose.

Chemicals {#S3}
---------

5-fluoroorotic acid was from Toronto Research Chemicals, Canada. Galactose, sucrose, raffinose, sorbitol, guanidine hydrochloride (GuHCl), 4′,6-diamidino-2-phenylindole (DAPI) and 2,3,5-triphenyltetrazolium chloride (TPC) were from Sigma Chemicals, USA. X-Gal (5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) was procured from DD Diagnostic Chemicals Limited, Canada.

Strains and plasmids {#S4}
--------------------

L-2729, *MAT***a*/****MAT***a** \[*PIN*^+^\] *cyc1::kan/cyc1-363 his3Δ1/his3Δ1 leu2-3,12/leu2Δ0 LYS2/lys2Δ0 ura3Δ0/ura3-52 TRP1/trp1-289 CAN1/can1-100 CYH2/cyh2* (see [Supplementary Information Methods](#SD1){ref-type="supplementary-material"} for origin); L-2762, *MAT*α *leu2Δ0 ura3Δ0 his3Δ1 cyc1::kan CYC8-GFP*; L-3045, *URA3* replacement of *CYC8* in L-2762; L-899, *MAT*α *cyc1Δ trp5 his1 rad52-1*; L-2814, \[*rho*^−^\] *kar1-Δ15* L-2762; L-3054, cytoductant of L-2814 with an \[*OCT*^+^\]L-2729; L-3055, *URA3* replacement of *CYC8* L-3054; L-3043, *MAT***a** his3*Δ0 leu2Δ0 met15Δ0 ura3Δ0 cyc8::kan* (from Yeast deletion library); SL873-4A, *MAT***a** *ura3-52 lys2 cyc1-1*. The strains MZ12-17, *MAT*α *trp1 leu2 ura3::ANB1-lacZ* and i182-242, *MAT*α *ura3 his3 trp1 cyc1-anb1::CYC7-lacZ* were kind gifts of R. Zitomer.

pCYC8PD is a *URA3 leu2-d 2μ* plasmid encoding aa: 465--966 of Cyc8 (see [Supplementary Information methods](#SD1){ref-type="supplementary-material"} for construction). pCYC8(1--453) is a *URA3 leu2-d* 2μ plasmid encoding an N-terminal functional fragment (aa:1--453) of Cyc8 and lacking the QN-rich C-terminus (see [Supplementary Information Methods](#SD1){ref-type="supplementary-material"} for source). pGAL-HSP104-KT encoding *URA3 GAL1p-HSP104K218TK620T*[@R25] and pCUP-CYC8YFP encoding *CUP1p-CYC8-YFP*[@R16] are pRS316 based plasmids. pRT81 is YEP24 based 2μ *URA3 CYC8*[@R11] (a kind gift of R. Trumbly). pRAA9 is YIp5 based *URA3 lys2Δ*2.6kb[@R26]. pES5 is pRS313 based *HIS3 GAL1p-HSP104* (a kind gift of S. Lindquist).

Assays for \[*OCT^+^*\] {#S5}
-----------------------

### Lactate assay {#S6}

\~2000 cells in 10 μL H~2~O were spotted on synthetic lactate and control synthetic glucose plates. Growth on lactate was examined after 7 days at 30 °C.

### Flocculation Assay {#S7}

Flocculation was assayed as described previously[@R27] with minor modifications. Yeast were grown to log phase and washed with 2 mM EDTA in 10 mM TrisHCl pH 8.0 and then re-suspended in the same buffer to an OD~600nm~ of 1. Next, 100 mM CaCl~2~ was added to a final concentration of 10 mM and the cell suspension was agitated to promote cell aggregation and then observed under a light microscope for cell-clumping.

### Invertase Assay {#S8}

Invertase was assayed following glucose repression as described previously[@R28] with minor modifications. Cells grown in YPD were washed twice to remove any traces of glucose and re-suspended in water to normalized cell concentrations. A 10 μL aliquot from each was spotted on Whatman No.3 filter paper that was pre-soaked in 5% sucrose in 10 mM pH 4.6 sodium acetate. The filter paper was allowed to ferment sucrose for 10 min at room temperature. Then, the petri-plate containing the filter was transferred to a 50 °C water bath. 1 ml of 0.1% triphenyltetrazolium chloride (TPC) dissolved in 0.5 M NaOH, which turns red when it reacts with glucose, was spread evenly on the filter. When the red color appeared in positive controls, the filter was blotted dry to stop the reaction and photographed. Strains being compared were always assayed simultaneously and with controls. The darkness of the red color reflects the level of invertase secreted from the cells assayed.

Cytoduction {#S9}
-----------

L-2729\[*OCT^+^*\] or L-2729\[*oct-*\] were donors and L-2814 \[*oct*^−^\] \[*rho*^−^\] which contains the *kar1-Δ15* mutation[@R15] was the recipient. After mating, cells were spread on synthetic glucose-His medium to select for single colonies and transferred to glycerol medium to score for non-petites. A non-petite His^+^ colony could either be a cytoductant or a triploid. These were distinguished by the ability of the *MAT*α cytoductant, but not the triploid, to mate with a *MAT***a** tester. Although \[*OCT^+^*\] inhibited the ability of the *MAT*α cytoductants to mate efficiently, they still mated more efficiently than the triploids. Cytoductants scored by this mating method were all verified to be cytoductants by genomic PCR amplification of the *KAR1* allele(s) using the primers-FWD: 5′CGGCGAATGTAACTTCTCCAAAAGATGGGAATCAC3′ and REV: 5′CGGCGTGCGGTGGAAATACAAATTGTCCATAAGAAAT3′. A true cytoductant showed a unique PCR product of \~1.02 Kb corresponding to the *kar1-Δ15* allele. A triploid showed two products of \~1.27 Kb and \~1.02 Kb corresponding respectively to the wild-type *KAR1* and *kar1-Δ15* alleles. Cytoductants were then assayed for growth on synthetic lactate and for invertase activity to assess the inheritance of \[*OCT^+^*\].

Transformation with cell lysates {#S10}
--------------------------------

Cells from L-2729 \[*OCT^+^*\] or L-2729 \[*oct*^−^\] were grown in YPD and lysed by agitation with 0.5 mm glass beads at 4 °C in STC buffer (1 M sorbitol, 10 mM CaCl~2~, 10 mM TrisHCl pH 7.5) containing a protease inhibitor cock-tail (Sigma Chemicals). Lysates were cleared of debris by centrifugation at 1000 × g and then co-transformed with *LEU2* plasmid pRS315 into spheroplasts made from L-2729 \[*oct*^−^\] using PEG3350 buffer[@R18]. Leu^+^ transformants were then examined for the gain of \[*OCT^+^*\] by a spot test on synthetic lactate plates. For control, the inability of the plasmid to transform cell lysates in the absence of recipient cells was confirmed.

Real-time PCR {#S11}
-------------

Total RNA was isolated from \[*oct*^−^\] L-2729, \[*OCT^+^*\] L-2729, \[*oct*^−^\] obtained by GuHCl treatment of \[*OCT^+^*\] L-2729 and *cyc8Δ* L3043 yeast cells, pre-grown to log phase under glucose-repressed conditions, using Ribopure^™^ yeast reagent (Ambion) according to the manufacturers instructions. Quality of RNA was checked by A~260~/A~280~ and equal amounts of RNA were reverse-transcribed using Superscript III reverse transcriptase (Invitrogen) as per the manufacturer's instructions using Oligo(dT)~12--18~ primers. Equal amounts of reverse-transcribed RNA (cDNA) were used with the following primers: *ACT1*: forward-5′TGGCCGGTAGAGATTTGACTGACT3′, reverse-5′TCGAAGTCCAAGGCGACGTAACAT3′; *ANB1:* forward-5′GTCACGCCAAGGTCCATTTGGTTA3′, reverse-5′AGCTTGCATGCTGTCACCCAATTC3′ ; *CYC7*: forward-5′AGTACGGGATTCAAACCAGGCTCT3′, reverse 5′TGGGTTCGTCAAGTACTCGGACA3′; *FLO1*: forward-5′ACTGCTTCACCTGCCATTGTTTCG3′, reverse-5′TGTTGTCTCACCGGTAGCACTGTT3′; *RNR3*: forward-5′CGCAAAGAGCCCGTTCAATTCGAT3′, reverse -5′ATCAGGGTGCACAGTGGTCATGTA3′; *SUC2*: forward-5′TGGGCTTCAAACTGGGAGTACAGT3′, reverse-5′AAACGAGACCAGGGACCAGCATTA3′. Real-time PCR was performed on DNA Engine2 (Opticon) qPCR machine and data were analyzed using the provided software. The PCR mixture (50 μl total) contained 25 μl of 2x SyberGreen PCR mastermix (Invitrogen), 5 μl of cDNA, 5 μl of 4 μM forward primer, 5 μl of 4 μM reverse primer and 10 μl DEPC-treated water. The protocol for PCR consisted of one denaturation at 95 °C for 10 min followed by 40 cycles of denaturation at 95 °C for 15 sec, annealing at 62 °C for 30 sec, and extension at 72 °C for 15 sec. The efficiency of PCR was 100% and R^2^ value was between 0.992 and 0.995. A standard curve was generated using a linear plasmid DNA containing yeast *ACT1* allele. For each sample, *ACT1* was used as an endogenous control to normalize mRNA levels. Experiments were done in triplicate and data are expressed as fold change in mRNA levels compared to that of an \[*oct*^−^\] yeast.

Supplementary Material {#S12}
======================
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![Over-expression of Cyc8's prion-like domain induces a *cyc8* mutant phenotype\
(**a**) As expected[@R9], the double *cyc1Δ cyc8Δ* mutant (L-3045) grows better on lactate than a single *cyc1Δ CYC8* mutant (L-2762). (**b**) Following over-expression of Cyc8's prion-like QN-rich domain (aa: 465--966) in L-2729 (*MAT***a/***MAT***a** *cyc1-363/cyc1::kan*) from pCYC8PD (2μ *URA3 leu2d*) on synthetic glucose-Leu medium[@R29], \~10^7^ cells per plate were spread on synthetic lactate (right) along with similarly treated controls with the empty vector, pHR81 (left). Plates were incubated for 15 days. (**c**) Even after Lac^+^ derivatives of pCYC8PD transformants of L-2729 obtained as in (a) were cured of pCYC8PD on 5-fluoroorotic acid medium[@R30], they grew on lactate and (**d**) exhibited constitutive invertase activity and higher flocculation than Lac^−^ L-2729 derivatives.](nihms100615f1){#F1}

![\[*OCT^+^*\] phenotypes are dominant\
**(a)** \[*OCT^+^*\] phenotypes are retained when crossed to \[*oct*^−^\]. Subclones of \[*OCT^+^*\] or \[*oct*^−^\] L-2729 (*MAT***a/***MAT***a** *cyc1Δ/cyc1Δ*) derivatives were crossed to L-899 (*MAT*α *his1 trp5 cyc1Δ CYC8* \[*oct*^−^\]). All triploids made with an \[*OCT^+^*\] L-2729 parent but none made with the \[*oct*^−^\] derivatives behaved like \[*OCT^+^*\]: they were Lac^+^ and had constitutive invertase activity. **(b)** Full-length Cyc8 protein fails to complement \[*OCT^+^*\] whereas, a Cyc8 fragment (aa: 1--453) lacking its QN-rich domain does. \[*OCT^+^*\] cells transformed with pRT81[@R11] or pCYC8(1--453) plasmids, respectively expressing the complete Cyc8 protein or a Cyc8 fragment (aa: 1--453), were tested for restoration of Cyc8's function (upper) by lactate growth assay or invertase activity. \[*OCT^+^*\] transformants with pCYC8(1--453) regained invertase activity after the plasmid was eliminated showing a masking of the phenotype and not a spontaneous loss. pRT81 expressed a functional Cyc8 since it successfully repressed invertase activity in L-3043 (*cyc8Δ*) and as opposed to the empty vector control p**H**R81(lower).](nihms100615f2){#F2}

![Inheritance of \[*OCT^+^*\] depends on Hsp104\
**(a)** \[*OCT^+^*\] is cured by growth on guanidine hydrochloride (GuHCl). Twenty-one subclones of L-2729 \[*OCT^+^*\] were transferred three times in a patch on complex media (YPD) + 4 mM GuHCl or for control on just YPD. Subsequently patches were tested for growth on synthetic lactate (and glucose for control) and invertase activity to score for \[*OCT^+^*\]. Growth on complex glycerol medium showed that they retained mitochondria. **(b)** Expression of dominant negative *HSP104-KT* cures cells of \[*OCT^+^*\]. Transformants of \[*OCT^+^*\] L-2729 with pGAL-HSP104-KT, encoding *HSP104-KT* under a *GAL* promoter, or with an empty vector control (pRS316) were transferred twice as patches on plasmid selective 2% galactose medium (+) to induce the expression of *HSP104-KT*, or on plasmid selective 2% glucose (−) for a no expression control. They were then grown on glucose to turn-off *HSP104-KT* expression and were finally tested for their \[*OCT^+^*\] status by measuring growth on synthetic lactate (and control glucose) medium and invertase activity.](nihms100615f3){#F3}

![\[*OCT^+^*\] is a prion form of the Cyc8 protein\
(**a**) Cyc8-YFP aggregates as cytoplasmic punctate dots in \[*OCT^+^*\] cells. \[*OCT^+^*\] and \[*oct*^−^\] derivatives of L-2729 transformed with pCUP-CYC8YFP were grown for 5 h in plasmid inducing 20 μM Cu^2+^ medium. Diffuse Cyc8-YFP fluorescence was seen in both \[*OCT^+^*\] and \[*oct*^−^\] cell's nuclei as visualized by DAPI counter-staining. Punctate fluorescent foci appeared in the cytoplasms of \~10--20% of the \[*OCT^+^*\] cells but not in the \[*oct*^−^\] controls. However, increased Cyc8-YFP induction eventually caused cytoplasmic and nuclear fluorescent aggregates to also appear in \[*oct*^−^\] cells (data not shown). Analogous *de novo* appearance of fluorescent aggregates has been observed for other prions following prolonged over-expression of the prion-domain fused to GFP in cells lacking the prion[@R3],[@R17]. (**b**) Transient loss of Cyc8 protein eliminates \[*OCT^+^*\]. *CYC8* was first replaced with *URA3* in an \[*OCT^+^*\] haploid (L-3054) and retention of \[*OCT^+^*\] was tested by assaying growth on lactate after restoring *CYC8* by crossing to *cyc1Δ CYC8* (SL873- 4A). Nine such individual *cyc8::URA3* replacements that we tested had all lost \[*OCT^+^*\]. Diploids from crosses of SL873-4A to isogenic \[*OCT^+^*\] (L-3054) and \[*oct*^−^\] (L-2762) strains were used as positive and negative controls. The possibility that transformation itself cured \[*OCT^+^*\] was eliminated because 40 Ura^+^ transformants of \[*OCT^+^*\] (L-3054) with pRAA9, a *lys2 URA3* integration plasmid linearized by BstEII to direct its integration into *LYS2*[@R26], all retained \[*OCT^+^*\] (data not shown).](nihms100615f4){#F4}

![\[*OCT^+^*\] cells exhibit de-repression of genes repressed by the Cyc8-Tup1 complex\
**(a)** \[*OCT^+^*\] cells express *lacZ* fused to *CYC7* or *ANB1* promoters. Patches from triploid yeast obtained by crosses of *MAT*α cells containing either *CYC7-lacZ* (strain: i182-248) or *ANB1-lacZ* (strain: MZ12-17) chimeras (kind gifts of R. Zitomer) to *MAT***aa** L-2729 derivatives (\[*oct*^−^\], \[*OCT^+^*\] or \[*oct*^−^\] obtained by GuHCl curing of \[*OCT^+^*\]) were tested for β-galactosidase activity at 30 °C by overlaying grown up plates with 5 mg ml^−1^ melted agarose containing the substrate X-Gal (0.25 mg ml^−1^), 6% dimethyl formamide, and 0.1% SDS. Positive β-galactosidase activity, as scored by appearance of blue color due to X-gal hydrolysis, indicated de-repression of the corresponding gene promoter. **(b)** \[*OCT^+^*\] cells show higher mRNA levels of Cyc8-repressed genes. mRNA levels of five Cyc8-repressed genes *CYC7*, *RNR3*, *FLO1*, *ANB1*, and *SUC2* were estimated with real-time PCR using equal amounts of cDNA reverse transcribed from isolated total RNA. Results show data from an \[*OCT^+^*\] L-2729 strain, an \[*oct*^−^\] derivative of this strain obtained by growth of the \[*OCT^+^*\] strain on 4 mM GuHCl (GuHCl cured \[*oct*^−^\]) and a *cyc8Δ* strain (L3043). The actin gene *ACT1*, which is not regulated by the Cyc8-Tup1 complex, was used to normalize mRNA levels and the results are expressed as fold change in the mRNA levels compared to the original \[*oct*^−^\] L-2729 control. Note the \[*oct*^−^\] control is the \[*oct*^−^\] strain in which \[*OCT^+^*\] was induced. The error bars indicate standard deviation (n=3).](nihms100615f5){#F5}
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